Browse Category

NASDAQ:MASI News 19 December 2025

Masimo Stock (NASDAQ: MASI) News, Forecasts and Analysis on Dec. 19, 2025: Investor Day Targets, Apple Verdict Tailwinds, and Why Shares Are Sliding

Masimo Stock (NASDAQ: MASI) News, Forecasts and Analysis on Dec. 19, 2025: Investor Day Targets, Apple Verdict Tailwinds, and Why Shares Are Sliding

Masimo Corporation’s stock is ending the week under pressure, even as the medical-technology company has stacked up several headline catalysts across 2025—from a sweeping strategic reset and long-range financial targets to major legal developments in its long-running dispute with Apple. As of Friday, Dec. 19, 2025, MASI shares were trading around $132, down roughly 3% on the day after opening near $136 and touching an intraday low near $132, implying a market capitalization of about $7.7 billion. So what’s going on with Masimo stock right now—and what do current forecasts and recent company updates suggest investors are weighing heading into
19 December 2025

Stock Market Today

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

7 February 2026
New York, Feb 7, 2026, 14:17 ET — Market closed. Advanced Micro Devices (AMD.O) shares finished Friday up 8.2% at $208.44, recovering some ground after a volatile week that punished chipmakers on guidance and AI competition worries. The snapback matters because AMD’s midweek slide showed how quickly the market is willing to reprice “AI winners” when the outlook does not clear a high bar. With U.S. data now set to land in a bunch next week, traders are also bracing for fresh swings in rate-cut bets that tend to hit growth stocks first. Friday’s move came as chip stocks led
Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

7 February 2026
Netflix shares rose 1.6% to $82.20 Friday as the Justice Department expanded its antitrust review of the company’s planned $82.7 billion Warner Bros Discovery acquisition. A Wall Street Journal report said investigators are probing possible anti-competitive tactics. Director Reed Hastings reported a transfer of 241,944 shares via a family trust, according to an SEC filing.
Go toTop